Eric Bjerkholt
Board Member
Metagenomi Therapeutics, Inc. (MGX)Board Member
Cerus Corp (CERS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Bjerkholt
Eric Bjerkholt is recorded as CFO at Mirum Pharmaceuticals, Inc. (MIRM), Board Member at Metagenomi Therapeutics, Inc. (MGX) and Board Member at Cerus Corp (CERS). Metagenomi Therapeutics, Inc. reported in an 8-K filed January 16, 2025 that Eric Bjerkholt was appointed director, effective January 27, 2025. Cerus Corp reported in an 8-K filed June 11, 2024 that Eric Bjerkholt was appointed Director, effective June 5, 2024. Mirum Pharmaceuticals, Inc. reported in an 8-K filed September 11, 2023 that Eric Bjerkholt was appointed Chief Financial Officer, effective September 11, 2023. The proxy statement of Mirum Pharmaceuticals, Inc. reports total compensation of $3,246,216 for Eric Bjerkholt in fiscal 2025, including a base salary of $520,000. Disclosed compensation is on record for 4 fiscal years. Eric Bjerkholt has spoken on 11 earnings calls across 1 company, most recently for Mirum Pharmaceuticals, Inc. on August 5, 2026.
“approved an increase in the size of the Board from five directors to six directors and, upon recommendation of the Nominating and Corporate Governance Committee, appointed Eric Bjerkholt to serve as a director of the Board, each effective as of January 27, 2025”
“The Company's stockholders elected each of the three nominees named below to the Board of Directors to serve until the 2027 Annual Meeting of Stockholders or until his respective successor has been duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2018-01-01–present
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Mirum Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Peetz CEO
- Michael Grey CEO
- Peter Radovich COO
- Lon Cardon, Ph.D., FMedSci Board Member
- Saira Ramasastry Board Member
- Timothy Walbert Board Member
- To approve Board Member
- William Fairey Board Member
Leadership on record at Cerus Corp
Other people whose current roles at this company are on record from its filings.
- Vivek Jayaraman CEO, COO, Board Member
- William M. Greenman CEO, Chairman, Board Member
- William "Obi" Greenman Chairman
- William “Obi” Greenman Chairman
- Kevin Green CFO
- Vivek K. Jayaraman COO
- Chrystal Jensen General Counsel
- Ann Lucena Board Member
- Daniel N. Swisher, Jr. Board Member
- Dean Gregory Board Member
Leadership on record at Metagenomi Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jian Irish CEO, COO, Board Member
- Pamela Wapnick CFO
- Matthew L. Wein General Counsel
- Eric Bjerkholt, M.B.A. Board Member
- Juergen Eckhardt Board Member
- Juergen Eckhardt, M.D., M.B.A. Board Member
- Laurence Reid Board Member
- Willard H. Dere Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | $520,000 | $3,246,216 |
| 2024 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | $500,000 | $2,006,255 |
| 2023 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | $151,562 | $4,337,928 |
| 2022 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.